Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Ilker K. Sariyer

Temple University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 23, 2026 · JOURNAL ARTICLE

Triple-Target CRISPR Strategy to Block HIV Entry and Replication in Permissive Cells

Human Gene Therapy

Early-stage in vitro and ex vivo proof-of-concept work demonstrating a novel triple-target CRISPR strategy, not yet tested in vivo or clinically, with no efficacy or safety data in human subjects.

PreliminaryKamel Khalili Anna Bellizzi Zahra Safaei

Reported

Replication suppressionprofound reduction

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support